Acumen Pharmaceuticals, Inc.

ABOS

NASDAQ

Healthcare

Biotechnology

Newton, VA, US61 employeesacumenpharm.com

$2.70

+0.15(5.9%)

52W $0.90 – $3.37

AI-generated

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease.

$164MMkt Cap

—Rev TTM

-$133MNI TTM

-1.2xP/E TTM

Latest Earnings

10-Q

Q3 FY2025Nov 11, 2025

10-Q for Q3 FY2025 was filed on 2025-11-12. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Financial Results

Mar 25, 2026

of this Report (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as

View filing →

Material Agreement+3 More

Mar 15, 2026

Entry into a Material Definitive Agreement. Securities Purchase Agreement On March 13, 2026, Acumen Pharmaceuticals, Inc. (the “ Company ”) entered into a Secur

View filing →

Regulation FD

Jan 11, 2026

of this Report (including Exhibit 99.1), is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Industry Biotechnology

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
IRDOpus Genetics, Inc.	$4.55	-2.99%	$324M	-57.6
ALECAlector, Inc.	$2.40	-5.14%	$265M	-1.5
FATEFate Therapeutics, Inc.	$1.22	-1.61%	$142M	-1.0
SPROSpero Therapeutics, Inc.	$2.44	-0.61%	$141M	-3.0
AGENAgenus Inc.	$3.33	-1.91%	$128M	1133.3
SEERSeer, Inc.	$1.71	+0.29%	$96M	-1.3
MCRBSeres Therapeutics, Inc.	$9.25	+4.43%	$89M	13.5
INOInovio Pharmaceuticals, I...	$1.13	-35.06%	$61M	-8.9

Company Profile

CIK0001576885

ISINUS00509G2093

CUSIP00509G209

Phone434 297 1000

Address427 Park Street, Newton, VA, 22902, US

SEC EDGAR